Relay Therapeutics, Inc. Common Stock | RLAY

Daily Technical Analysis of Relay Therapeutics, Inc. Common Stock

Relay Therapeutics is only slightly up on the day, shares traded 0.81% higher on the day. It looks like RLAY may be interacting with a slightly angled support line. This area could represent a pivot point that it moves up from. Relay Therapeutics hasn't been that impressive in terms of its 3 month momentum, it has been breaking down lower so we'll see if it can turn things around and move up from here.

If the price bounces off of the support and moves up it'll probably head up to the $3.12 level, at which point it may hit some selling pressure. There aren't very obvious support levels beneath this point. So put those stop losses on, this thing has room to fall if buyers don't come in at this level.

Analyst Ratings for Relay Therapeutics By Price Target And Rating

The analysts are pretty neutral on Relay Therapeutics right now, so not much useful information here. The current Analysts Sentiment Score is 0.22. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. HC Wainwright announced a lowering of their price target to $17.00 from $19.00 on 2023-12-11. Oppenheimer reiterated a rating of Outperform on 2023-08-09 and added a price target of $33.00. SVB Securities initiated a rating of Outperform on 2023-08-08. Leerink Partnrs reiterated a rating of Outperform on 2023-08-08. JMP Securities announced a lowering of their price target to $24.00 from $28.00 on 2023-05-05. On 2023-04-20 Stifel Nicolaus lowered their price target by -10.53% to $34.00. Jefferies Financial Group upgraded from Underperform to Hold on 2023-04-20 but they lowered their price target by -21.88% to $12.50 from a previous target of $16.00. On 2023-04-19 Barclays lowered their price target by -34.78% to $15.00. Raymond James upgraded from Outperform to Strong-Buy on 2023-04-19 and added a price target of $29.00. JPMorgan Chase & Co. provided a price target decease of -30.95% to $29.00 from $42.00 on 2023-04-19.

Earnings Per Share (EPS) Estimates By Year and Quarter

Short interest for Relay Therapeutics

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Social Sentiment for Relay Therapeutics

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.